Searchable abstracts of presentations at key conferences in endocrinology

ea0037ep56 | Adrenal cortex | ECE2015

Review of clinical presentation of primary hyperaldosteronism and identify unique features in our cohort

Lee Daphne , Shakoor Shaikh A K K Abdul , Pua Uei , Wong Daniel , Quek Lawrence

Aim: Review of clinical presentation of primary hyperaldosteronism (PHA) and identify unique features in our cohort.Method: Patients with PHA were identified from patients who underwent adrenal vein sampling (AVS) at our centre until October 2014.Results: 45 PHA patients (32 males, mean age of 50 years, 33 older than 45 years) were identified after confirmation with high aldosterone:renin ratio >15 and/or positive saline suppre...

ea0037ep57 | Adrenal cortex | ECE2015

To identify usefulness of adrenal vein sampling in clinical management of primary hyperaldosteronism

Lee Daphne , Shakoor Shaikh A K K Abdul , Pua Uei , Wong Daniel , Quek Lawrence

Aim: To identify usefulness of adrenal vein sampling (AVS) in clinical management of primary hyperaldosteronism (PHA).Method: Biochemical and radiological review (by two independent radiologists) of 48 AVS in 45 patients with PHA who underwent CT adrenals/AVS.Results: CT adrenal findings were: 31/45 (68.9%) unilateral nodule (one had two nodules unilaterally), 5/45 (11.1%) bilateral nodules, 7/45 no nodules, 1/45 bilateral bulky ad...

ea0037ep1270 | Clinical Cases–Thyroid/Other | ECE2015

Severe hypocalcaemia and hypomagnesaemia secondary to omeprazole

Min-Li Teo Claire , Quek Timothy Peng Lim , Abdul Shakoor Shaikh A K K

Introduction: Proton pump inhibitors (PPIs) are commonly prescribed drugs. We report a case of severe hypocalcaemia secondary to omeprazole-induced hypomagnesaemia.Case report: A 85-year-old Chinese man with stage 4 chronic kidney disease was admitted to our hospital in Jun 2014 with vomiting and weakness. On admission, he was severely hypocalcaemic (adjusted calcium 1.37 mmol/l (RI: 2.15–2.58)) and hypomagnesaemic (Mg 0.1 mmol/l (RI: 0.7–1.0))...

ea0032p419 | Diabetes | ECE2013

Improvement in sympathetic cardiac autonomic functions after 6 months of comprehensive yogic breathing program in patients with diabetes

Jyotsna V P , Singla R , Ambekar S , Dhawan Anju , Gupta Nandita , Sreenivas V , Deepak K K

Aims and objectives: To assess the effect of Comprehensive Yogic Breathing Program on glycemic control, quality of life, and cardiac autonomic functions in diabetes.Material and methods: This is a prospective randomized controlled intervention trial. 120 diabetes patients who were having HbA1c between 6 and 8% for atleast 6 months were selected. Oral drug dose was adjusted to keep the HbA1c between 6 and 8. Plasma fasting glucose, post prandial plasma gl...

ea0031p360 | Thyroid | SFEBES2013

Homozygous resistance to thyroid hormone: can cardiac complications be prevented?

Moran Carla , Al-Johani Amal , Rajanayagam Odelia , Halsall David , Habeb Abdelhadi , Chatterjee V K K

Resistance to thyroid hormone (RTH) is usually due to heterozygous mutations in THRB gene with rare cases being homozygous for receptor defects. We describe an RTH case due to a homozygous TRβ mutation (R243Q).The Proband (male, 8.4 years), was born at term with low birth weight (1.9 kg) to consanguineous parents. He has a prominent nasal bridge, goitre, low body weight (10th centile), recurrent tonsillitis, hyperactivity and has mild hearing impair...

ea0031p365 | Thyroid | SFEBES2013

The challenge of managing refractory amiodarone-induced Graves' disease in resistance to thyroid hormone

Moran Carla , Chatterjee V K K , Page M D , Owen Penny

A 42-year-old man with resistance to thyroid hormone (RTH) and a recognised thyroid hormone receptorβ mutation (R383C) mutation, presented with atrial fibrillation (AF) which was resistant to DC cardioversion until initiation of amiodarone therapy.As expected in RTH, his baseline TFTs were abnormal (FT4 34.6 pmol/l, TSH 2.27 mU/l), but rose further (FT4 45 pmol/l, TSH 0.93 mU/l) following commencement of amiodarone. However, sh...

ea0024oc2.8 | Oral Communications 2 (Brief Communications) | BSPED2010

Radio-iodine therapy for autoimmune hyperthyroidism. A two centre, retrospective evaluation of practice and outcomes

Wnuk W , Balan K K , Cheetham T D , Acerini C L

Radio-iodine (I131) (RI) is regarded as an effective therapy for patients with autoimmune hyperthyroidism (AH). Treatment protocols and outcomes are well defined in adult endocrinology practice but not for children and adolescents where RI is now considered a safe therapy option after relapse following anti-thyroid drugs (ATD). We retrospectively evaluated the use of RI in 36 patients (6M) with AH from 2 regional units located in the North and East of England. Data ...

ea0034p423 | Thyroid | SFEBES2014

Autoimmune thyroid disease in the presence of resistance to thyroid hormone or TSH-secreting pituitary tumour: a diagnostic challenge

Moran Carla , Koulouri Olympia , Talbot Fleur , Mitchell Catherine , Schoenmakers Nadia , Lyons Greta , Gurnell Mark , Chatterjee V K K

Background: Hyperthyroxinaemia with non-suppressed TSH, due to resistance to thyroid hormone (RTH) or TSH-secreting pituitary tumour (TSHoma), can be difficult to diagnose, particularly with coincident autoimmune thyroid disease (AITD).Methods: To determine presentation patterns of AITD coincident with RTH or TSHoma, we analysed our cohort of cases with dual diagnoses.Results: Nine patients with RTH had AITD. Six had Graves’ d...

ea0023oc1.4 | Oral Communications 1 | BSPED2009

A multisystem disorder associated with defective selenoprotein synthesis and a thyroid signature

Padidela R , Al-Ali N , Schoenmakers E , Agostini M , Rajanayagam O , Dattani M T , Chatterjee V K K

The superfamily of ~25 human selenoproteins includes antioxidant and oxidoreductase enzymes together with other proteins of unknown function. We describe a child with a multisystem disorder involving deficiencies of several selenoproteins, identified on the basis of abnormal thyroid function.A 3.6-year-old male was referred with elevated free thyroxine (FT4 – 44.4 pmol/l (N 12–22)), low free triiodothyronine (FT3 &#...

ea0026p456 | Thyroid cancer | ECE2011

Thr300Ala ATG16L1 polymorphism influences susceptibility to and the prognosis of epithelial cell derived thyroid carcinoma

Huijbers A , Plantinga T S , Oosting M , Joosten L A B , Aben K K H , Netea M G , Hermus A R M M , Netea-Maier R T

Background: Loss of autophagy protein ATG16L1 enhances endotoxin-induced interleukin 1β (IL1β) production. IL1β has been found to have antineoplastic effects in thyroid malignancies. We hypothesized that a missense polymorphism in ATG16L1 autophagy gene (Thr300Ala) results in changes in the function of the molecule and influences susceptibility to and prognosis of epithelial cell derived thyroid carcinoma (TC).Objective: i) To assess the f...